Low Z‐4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen

Low steady‐state levels of active tamoxifen metabolites have been associated with inferior treatment outcomes. In this retrospective analysis of 406 estrogen receptor‐positive breast cancer (BC) patients receiving adjuvant tamoxifen as initial treatment, we have associated our previously reported th...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Thomas Helland, Bjørn Naume, Steinar Hustad, Ersilia Bifulco, Jan Terje Kvaløy, Anna Barbro Sætersdal, Marit Synnestvedt, Tone Hoel Lende, Bjørnar Gilje, Ingvil Mjaaland, Kjetil Weyde, Egil Støre Blix, Gro Wiedswang, Elin Borgen, Daniel Louis Hertz, Emiel Adrianus Maria Janssen, Gunnar Mellgren, Håvard Søiland
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Wiley 2021-04-01
Saila:	Molecular Oncology
Gaiak:	4OHtam concentration threshold endoxifen outcomes therapeutic drug monitoring
Sarrera elektronikoa:	https://doi.org/10.1002/1878-0261.12865
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!